Effects of celecoxib augmentation of antidepressant or anxiolytic treatment on affective symptoms and inflammatory markers in patients with anxiety disorders: exploratory study-Reference-Cited by-同舟云学术

Effects of celecoxib augmentation of antidepressant or anxiolytic treatment on affective symptoms and inflammatory markers in patients with anxiety disorders: exploratory study

Published:2021-03-12 Issue:3 Volume:36 Page:126-132
ISSN:0268-1315
Container-title:International Clinical Psychopharmacology
language:en
Short-container-title:

Author:

Elnazer Hesham Y.,Sampson Anthony P.,Baldwin David S.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Psychiatry and Mental health

Reference39 articles.

1. Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study;Abbasi;J Affect Disord,2012

2. Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial;Akhondzadeh;Depress Anxiety,2009

3. Inflammatory biomarkers predict depressive, but not anxiety symptoms during aging: the prospective Sydney Memory and Aging Study;Baune;Psychoneuroendocrinology,2012

4. Cerebrospinal fluid interleukin-6 in obsessive-compulsive disorder and trichotillomania;Carpenter;Psychiatry Res,2002

5. Systematic review and meta-analysis of the association between peripheral inflammatory cytokines and generalised anxiety disorder;Costello;BMJ Open,2019

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Critical View on New and Future Antidepressants;Clinical Psychopharmacology and Neuroscience;2024-02-15

2. Interleukin-1 beta in psychosocial stress;Stress: Immunology and Inflammation;2024

3. Deciphering the mechanisms of reciprocal regulation or interdependence at the cannabinoid CB1 receptors and cyclooxygenase-2 level: Effects on mood, cognitive implications, and synaptic signaling;Neuroscience & Biobehavioral Reviews;2023-12

4. Innovation in psychopharmacology;International Clinical Psychopharmacology;2023-07-10

5. Alleviating anxiety and taming trauma: Novel pharmacotherapeutics for anxiety disorders and posttraumatic stress disorder;Neuropharmacology;2023-03